Full text article
Taub B. Jonathan Ledgard believes imagination could save the world. The New Yorker. Published online September 23, 2019. Accessed August 21, 2022. Available from: https://www.newyorker.com/magazine/2019/09/23/jonathan-ledgard-believes-imagination-could-save-the-world
Tufekci Z. Data-driven medicine will help people ‒ but can it do so equally: technological advances threaten to make an unequal system crushingly more so. The New York Times. Available from: https://www.nytimes.com/interactive/2018/11/15/magazine/tech-design-inequality-health.html. Published November 15, 2018. Accessed August 21, 2022.
Mathers CD, Loncar D. Projections of Global Mortality and Burden of Disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. doi: 10.1371/journal.pmed.0030442.
Nundy S. Care after Covid. 1st ed. McGraw Hill; 2021.
American Society of Clinical Oncology. Continuing Education Program Mission Statement. Published 2017. Accessed August 23, 2022. Available from: https://www.asco.org/sites/new-www.asco.org/files/content-files/training-and-education/documents/CE-Mission-Statement.pdf
U. S. Preventive Services Task Force. Breast Cancer: Screening. Recommendation: Breast Cancer: Screening, Jan 11, 2016. Published January 11, 2016. Accessed August 5, 2022. Available from: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening
Harford JB. Breast-cancer early detection in low-income and middle-income countries: do what you can versus one size fits all. Lancet Oncol. 2011;12(3):306-312. doi: 10.1016/S1470-2045(10)70273-4.
Pisani P, Parkin DM, Ngelangel C, Esteban D, Gibson L, Munson M, et al. Outcome of screening by clinical examination of the breast in a trial in the Philippines. Int J Cancer. 2006;118(1):149-154. doi: 10.1002/ijc.21343.
Story HL, Love RR, Salim R, Roberto AJ, Krieger JL, Ginsburg OM. Improving Outcomes from Breast Cancer in a Low-Income Country: Lessons from Bangladesh. Int J Breast Cancer. 2012;2012:1-9. doi: 10.1155/2012/423562.
National Comprehensive Cancer Network. Gene expression assays for consideration of addition of adjuvant systemic therapy to endocrine therapy. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. version 5.2020, Invasive breast cancer BINV-N:1-4. Published July 15, 2020. Accessed August 21, 2022. Available from: https://www2.tri-kobe.org/nccn/guideline/breast/english/breast.pdf
Love R. By the Metrics Surgical Oophorectomy Plus Tamoxifen is the First Adjuvant Treatment Option for Premenopausal Women with Hormone Receptor Positive Breast Cancer. Archives of Breast Cancer. Published online January 28, 2021:8-13. doi: 10.32768/abc.2021818-13.
Love R. Adjuvant surgical oophorectomy efficacy according to hormonally-determined menstrual cycle phase. Global Journal of Medical Research (1). 2021;21(1).
Love R, Salim R. A guideline-created unfreedom for women with breast cancer. Journal of Gynecology & Obstetrics. 2017;1(20). Accessed August 21, 2022. Available from: http://www.scientificoajournals.org/pdf/jgo.020.pdf
NIH National Cancer Institute. SEER Cancer Statistics Review (CSR) 1975-2017. Surveillance, Epidemiology, and End Results Program. Published April 5, 2020. Accessed August 21, 2022. Available from: https://seer.cancer.gov/csr/1975_2017/browse_csr.php?sectionSEL=1&pageSE L=sect_01_table.26
Love RR, Baum M, Love SM, Straus AM. Clinical practice to address tamoxifen nonadherence. Breast Cancer Res Treat. 2020;184(3):675-682. doi: 10.1007/s10549-020-05912-y.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. version 5.2020, Invasive breast cancer. Principles of radiation therapy BINV-I. Published July 15, 2020. Accessed August 21, 2022. Available from: https://www2.tri-kobe.org/nccn/guideline/breast/english/breast.pdf
Rodin D, Jaffray D, Atun R, Knaul FM, Gospodarowicz M. The need to expand global access to radiotherapy. Lancet Oncol. 2014;15(4):378-380. doi: 10.1016/S1470-2045(14)70121-4.
Knaul FM, Farmer PE, Krakauer EL, De Lima L, Bhadelia A, Jiang Kwete X, et al. Alleviating the access abyss in palliative care and pain relief—an imperative of universal health coverage: the Lancet Commission report. The Lancet. 2018;391(10128):1391-1454. doi: 10.1016/S0140-6736(17)32513-8.
The Economist Intelligence Unit. The 2015 Quality of Death Index: Ranking palliative care across the world. The Economist. Published online 2015. Accessed August 21, 2022. Available from: https://impact.economist.com/perspectives/sites/default/files/2015%20EIU%20Quality%20of%20Death%20Index%20Oct%2029%20FINAL.pdf
Chin MH. Uncomfortable Truths — What Covid-19 Has Revealed about Chronic-Disease Care in America. New England Journal of Medicine. 2021;385(18):1633-1636. doi: 10.1056/NEJMp2112063.
Marmot M, Wilkenson R, eds. Social Determinants of Health. 2nd ed. Oxford University Press; 2005.
Institute of Medicine (US) Committee on Quality of Health Care in America. Crossing the Quality Chasm. National Academies Press; 2001. doi: 10.17226/10027.
Crisp N. Turning the World Upside down: The Search for Global Health in the 21st Century. 1st ed. Royal Society of Medicine Press; 2010.
Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. The Lancet. 1993;342(8883):1317-1322. doi: 10.1016/0140-6736(93)92244-N.
Love R, Ahamed S. Information technology tools for palliative care for populations. In: Silbermann M, ed. Palliative Care for Chronic Cancer Patients in the Community: Global Approaches and Future Applications. Springer Nature; 2021:15-28.
Love RR, Salim R. Affordable and high-quality outpatient adult medical care. Bangladesh Journal of Medicine. 2019;30(1):44-49. doi: 10.3329/bjmed.v30i1.39924.
Christensen C. The Innovator’s Prescription: A Disruptive Solution for Healthcare. 1st ed. McGraw Hill; 2009.
Copyright (c) 2022 Archives of Breast Cancer
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright©. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International License, which permits copy and redistribution of the material in any medium or format or adapt, remix, transform, and build upon the material for any purpose, except for commercial purposes.